Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid α-glucosidaseFrancesco Puzzo, Federico Mingozzi, Mathilde Cohen-Tannoudji et al.|Science Translational Medicine|2017Cited by 133
Determination of Anti-Adeno-Associated Virus Vector Neutralizing Antibody Titer with an <i>In Vitro</i> Reporter SystemAmine Meliani, Federico Mingozzi, Christian Leborgne et al.|Human Gene Therapy Methods|2015Cited by 112
Exposure to wild-type AAV drives distinct capsid immunity profiles in humansKlaudia Kuranda, Federico Mingozzi, Priscilla Jean-Alphonse et al.|Journal of Clinical Investigation|2018Cited by 103
Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance InductionSang-oh Han, Dwight D. Koeberl, Giuseppe Ronzitti et al.|Molecular Therapy — Methods & Clinical Development|2017Cited by 77
Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance InductionSang-oh Han, Dwight D. Koeberl, Giuseppe Ronzitti et al.|Molecular Therapy — Methods & Clinical Development|2019Cited by 6